Jet Injector Drug Delivery: Promise and Pitfalls

Two men, Nick A. (left) and Nigel (right), sit at a white table, engaging in a lively and friendly conversation. Both wear checkered shirts and lavalier microphones, suggesting a filmed discussion or interview. Nick holds tissue samples in one hand and gestures animatedly, while Nigel smiles in response. Each has a white mug labeled with their name and a purple star logo. The background is a bright white, creating a clean and professional studio setting.
Resources

Jet Injector Drug Delivery: Promise and Pitfalls

Topic: Bio Break
YouTube video thumbnail

In this episode of Bio Break, Nick and Nigel dive into the world of jet injector drug delivery. This needle-free method, made popular in science fiction and real-world vaccines, is still used today. But while the idea of a high-pressure, pain-free injection sounds ideal, the conversation uncovers key limitations.

What Is a Jet Injector?

Jet injectors deliver drugs by forcing liquid medication through the skin using high pressure, eliminating the need for a needle. That pressure forms a thin stream that penetrates the skin, ideally resulting in less pain than traditional injections. The technology has been around since the 1960s and remains popular in certain applications.

Less Pain, More Problems?

While jet injector drug delivery may reduce pain, Nigel highlights concerns. The high pressure can cause side spray, potentially wasting expensive medications. There’s also the risk of cross-contamination, especially when parts of the injector are reused. Additionally, some advanced drugs—like those using lipid nanoparticles for mRNA vaccines—may be incompatible due to shear forces that can damage sensitive payloads.

Why Jet Injectors Are Still Around

Despite the challenges, jet injectors offer clear benefits in usability. They provide a quick, needle-free option that appeals to patients and practitioners alike. However, understanding their limitations is key to deciding when they’re the right tool for the job.

Learn more about StarFish Medical.

A gloved hand holds a COVID-19 lateral flow test in front of a white bathroom sink and tiled wall. Overlay text reads: ‘From ELISA to DIY?’ in bold white font on a black background.

ADLM Diagnostics Innovation and COVID Testing

Nick Allan and Nigel Syrotuck reflect on recent ADLM diagnostics innovation and how it has shaped the future of clinical testing.

A patient lies with eyes closed while a clinician marks dotted surgical lines on her face with a skin marker. The patient wears a surgical cap. Overlay text reads: ‘More than a procedure?’ in bold font on a white highlight box.

Patient-Centered Field Research in Medtech

In this Before the Build episode, Eric Olson and Paul Charlebois reflect on the value of patient-centered field research—and how firsthand observation can reframe design priorities and impact outcomes in profound ways.

loved hand holding a blood vial in front of blurred Chicago skyline. Overlay text says ‘From vial… To Chicago?’ in bold white font on black background.

Laboratory Diagnostics Showcase at ADLM 2025

Each summer, the laboratory diagnostics showcase hosted by the Association for Diagnostics & Laboratory Medicine (ADLM) draws industry leaders to Chicago.

Thumbnail showing a vial of clear contrast agent on the left, with a red dotted arrow pointing to an X-ray image of a skull displayed on a tablet held by a person in a white coat. Overlay text reads “Not approved here?” in bold black and white text.

Understanding Contrast Agents in Imaging

Nigel and Nick explore how contrast agents in imaging support medical device trials and diagnostics. While bones appear clearly in standard X-rays, soft tissues like those in the nasal cavity often require contrast agents to become visible.